Start with a 30-minute introduction call
No sales pitch: just honest assessment
Ready to discuss your pharma market entry strategy? Want to learn more about how I can help with your commercial growth or business optimization? Schedule a call. I'll help you understand where you are, what's realistic, and whether we're a fit to work together.
kmaduschke@clintechstrategy.com
I typically respond within 24 hours. Helpful things to include: your product, your current stage, and the challenge you are working on.
View My Calendar & Book a Time
Based in EU, flexible with US timezone for real-time collaboration when you need it.
Before the call: You'll receive a short questionnaire (3-5 questions) so I can prepare and make our time together valuable.
After the call: If we're aligned, I'll send a written proposal within 3-5 business days. You can review with your team, board, or investors before deciding.
Yes, I'm happy to sign mutual NDAs before discussing proprietary technology or business strategy. I take confidentiality seriously and can provide references from previous clients.
The introductory call is complimentary. Paid work often starts as a single 90-minute consultation, which is usually enough for a specific question or a second opinion. Broader questions tend to need three or four hours spread across two or three meetings, so we both have time to think between sessions and you have time to work on what comes out of them. If your deck is the real issue, the Pitch Workshop covers that as a fixed scope at a fixed price.
Engagements are project-based with clear deliverables and milestones. Pricing depends on scope and timeline. For example, a Market Readiness Assessment starts around €7,500; Comprehensive Strategy engagements range from €60,000-€125,000 in phased investments. Fractional CxO retainers can range €8,000-€15,000/month. I provide detailed proposals after our initial conversation so you know exactly what you're getting.
Absolutely. I'm based in the EU with deep expertise in European regulatory requirements (EMA, GDPR, DACH markets). I'm bilingual (English/German C1) and work flexibly across US and EU timezones.
I work with health tech companies from early-stage (pre-revenue, preparing for first pharma pilots) through growth-stage (Series A+, scaling commercial operations). The common thread is they're all selling into pharmaceutical R&D and clinical trials.
I typically work with 2-4 clients simultaneously. If I'm at capacity, I maintain a waitlist and can provide referrals to trusted colleagues. As of August 2026, I can accept up to 2 new clients, with renewed availability expected by early November.